Table 2

Effects of plasma concentrate transfusion on haemostasis of a patient with vWD type 2B

Time after transfusionF VIII:C (%)vWF:Ag (%)RiCoF (%)Platelet count
(× 109/l)
0 min37 42 14 12
30 min8052 112 30
24 hours 30 min58 83 56 33
48 hours 30 min70 100 70 32
  • Haemate HS (30 IU/kg body weight) was infused for three subsequent days. Coagulation analysis including F VIII:C, vWF:Ag, ristocetin cofactor (RiCoF), and platelet counts was performed 30 minutes after infusion.